Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nudix hydrolase 14 (NUDT14) is a member of the Nudix hydrolase enzyme family that is responsible for the hydrolysis of UDP-glucose (UDPG) to glucose 1-phosphate and UMP. NUDT14 also has activity toward ADP-ribose and ADP-glucose, and can act on a limited range of nucleotide-diphosphate derivatives, but has its highest activity with UDP-glucose. By eliminating potentially toxic nucleotide metabolites and regulating the cellular availability of nucleotide substrates, NUDT14 plays a significant role in cellular metabolism and protein glycosylation pathways, such as N-glycan biosynthesis. NUDT14 shows redundancy and overlap with other Nudix enzymes, notably NUDT5, and is structurally similar to several other members of its family. Expression profiling identifies NUDT14, along with NUDT1 and NUDT5, as being upregulated in multiple cancer types, suggesting a possible, albeit not fully characterized, role in tumorigenesis and cancer metabolism. However, there are currently no known drugs or small molecules reported to directly target NUDT14, and no validated diagnostic or patient stratification biomarkers have been established for clinical use based on referenced literature. Alternative spliced transcript variants and isoforms of NUDT14 exist. There are no indications of misspelling, redundancy, or other significant informational issues in the reference nomenclature or gene data provided.
Enzyme substrate hydrolysis (no known approved therapeutic inhibitors or agonists)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nudix hydrolase 14 (NUDT14).